Skip to Content

User Reviews for Rituxan to treat Microscopic polyangiitis

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Reviews for Rituxan

No reviews have yet been submitted. Be the first to review this drug.

More about Rituxan (rituximab)

Consumer resources

Professional resources

Related treatment guides

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Manufacturers

Drug Class

Antirheumatics
CD20 monoclonal antibodies

Related Drugs

Diffuse Large B-Cell Lymphoma prednisone, rituximab, cyclophosphamide, doxorubicin, Cytoxan, vincristine, More...

Chronic Lymphocytic Leukemia Imbruvica, Venclexta, rituximab, cyclophosphamide, ibrutinib, Cytoxan, More...

Granulomatosis with Polyangiitis azathioprine, rituximab, More...

Follicular Lymphoma rituximab, Gazyva, Zydelig, Copiktra, Intron A, copanlisib, More...

5 more conditions...

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 Mar 2019), Cerner Multum™ (updated 1 Mar 2019), Wolters Kluwer™ (updated 28 Feb 2019) and others. Refer to our editorial policy for content sources and attributions.